Geisinger Clinic | Geisinger Danville - Anesthesiology

Research site

(Unclaimed)

Location

100 N. Academy Avenue, Danville, Pennsylvania, United States of America

Site insights

Top conditions

Top treatments

Setmelanotide

Semaglutide

Verapamil

Nitroglycerin

Nicardipine

Parent organization

This site is a part of Geisinger Clinic

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

6 of 15 total trials

A Randomized, Controlled Trial to Evaluate the Safety and Effectiveness of the Route 92 Medical Reperfusion System (SUMMIT MAX)

The SUMMIT MAX study is a prospective, randomized, controlled, interventional clinical trial to evaluate the safety and effectiveness of the Route 92...

Active, not recruiting

Acute Ischemic Stroke

Device: Route 92 Medical Reperfusion System

Clinical Evaluation of the AccuCinch® Ventricular Restoration System in Patients Who Present With Symptomatic Heart Failure With Reduced Ejection Fraction (HFrEF): The CORCINCH-HF Study

Prospective, randomized, open-label, international, multi-center clinical study to evaluate the safety and efficacy of the AccuCinch Ventricular Rest...

Enrolling

Dilated Cardiomyopathy

Heart Failure With Reduced Ejection Fraction (HFrEF)

Device: AccuCinch Ventricular Restoration System

Drug: Guideline-Directed Medical Therapy

DAYBREAK: A Study of Setmelanotide in Patients With Specific Gene Variants in the MC4R Pathway

A 2-stage (open-label run-in, followed by randomized, double-blind, placebo-controlled withdrawal) trial of setmelanotide in patients with obesity an...

Active, not recruiting

Genetic Obesity

Drug: Placebo

Drug: Setmelanotide

EMANATE: A Study of Setmelanotide in Patients With Specific Gene Variants in the MC4R Pathway

The protocol describes a randomized, double-blind, placebo-controlled trial with independent sub-studies of setmelanotide in patients with obesity an...

Enrolling

Genetic Obesity

Obesity

Drug: Placebo

Drug: Setmelanotide

Research Study on Whether a Combination of 2 Medicines (NNC0194 0499 and Semaglutide) Works in People With Non-alcoholic Steatohepatitis (NASH)

This study is being done to see if a combination of 2 medicines (called NNC0194-0499 and semaglutide) can reduce liver damage in patients with non al...

Active, not recruiting

Non-alcoholic Steatohepatitis

Drug: Placebo (NNC0194-0499)

Drug: NNC0174 0833 placebo

Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH) (ESSENCE)

Semaglutide is a medicine studied in patients with NASH. Semaglutide is a well-known medicine, which is already used by doctors to treat type 2 diabe...

Enrolling

Non-alcoholic Steatohepatitis

Drug: Placebo

Drug: Semaglutide